Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/7301
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBhaumik, M.-
dc.contributor.authorMuller, V.-
dc.contributor.authorRozaklis, T.-
dc.contributor.authorJohnson, L.-
dc.contributor.authorDobrenis, K.-
dc.contributor.authorBhattacharyya, R.-
dc.contributor.authorWurzelmann, S.-
dc.contributor.authorFinamore, P.-
dc.contributor.authorHopwood, J.-
dc.contributor.authorWalkley, S.-
dc.contributor.authorStanley, P.-
dc.date.issued1999-
dc.identifier.citationGlycobiology, 1999; 9(12):1389-1396-
dc.identifier.issn0959-6658-
dc.identifier.issn1460-2423-
dc.identifier.urihttp://hdl.handle.net/2440/7301-
dc.descriptionCopyright © 1999 Oxford University Press-
dc.description.abstractMucopolysaccharidosis type III A (MPS III A, Sanfilippo syndrome) is a rare, autosomal recessive, lysosomal storage disease characterized by accumulation of heparan sulfate secondary to defective function of the lysosomal enzyme heparan N- sulfatase (sulfamidase). Here we describe a spontaneous mouse mutant that replicates many of the features found in MPS III A in children. Brain sections revealed neurons with distended lysosomes filled with membranous and floccular materials with some having a classical zebra body morphology. Storage materials were also present in lysosomes of cells of many other tissues, and these often stained positively with periodic-acid Schiff reagent. Affected mice usually died at 7-10 months of age exhibiting a distended bladder and hepatosplenomegaly. Heparan sulfate isolated from urine and brain had nonreducing end glucosamine- N -sulfate residues that were digested with recombinant human sulfamidase. Enzyme assays of liver and brain extracts revealed a dramatic reduction in sulfamidase activity. Other lysosomal hydrolases that degrade heparan sulfate or other glycans and glycosaminoglycans were either normal, or were somewhat increased in specific activity. The MPS III A mouse provides an excellent model for evaluating pathogenic mechanisms of disease and for testing treatment strategies, including enzyme or cell replacement and gene therapy.-
dc.description.statementofresponsibilityMantu Bhaumik, Vivienne J.Muller, Tina Rozaklis, Linda Johnson, Kostantin Dobrenis, Riddhi Bhattacharyya, Sarah Wurzelmann, Peter Finamore, John J.Hopwood, Steven U.Walkleya, and Pamela Stanley-
dc.language.isoen-
dc.publisherOxford University Press-
dc.source.urihttp://glycob.oxfordjournals.org/cgi/content/abstract/9/12/1389-
dc.subjectMPS III A-
dc.subjectmouse-
dc.subjectpathogenesis-
dc.subjectSanfilippo syndrome-
dc.titleA mouse model for mucopolysaccharidosis type III A (Sanfilippo syndrome)-
dc.typeJournal article-
dc.identifier.doi10.1093/glycob/9.12.1389-
pubs.publication-statusPublished-
Appears in Collections:Aurora harvest 5
Paediatrics publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.